Y+Z9+U0646]1/$I/~Y|'?/ML|L|
SYSTEM PROCESSING...
Y+Z9+U0646]1/$I/~Y|'?/ML|L|
SYSTEM PROCESSING...
Posted: 2025-04-12 00:41:56 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-12 00:42:11 UTC
Verified By
Rollup News
The OptiTROP-Breast01 phase 3 trial showed that sacituzumab tiristam improved progression-free survival in patients with metastatic triple-negative breast cancer compared to chemotherapy.
Sacituzumab tiristam demonstrates superior progression-free survival in metastatic triple-negative breast cancer.
OptiTROP-Breast01 phase 3 trial results.
Metastatic triple-negative breast cancer treatment.